Dr. Hurria has disclosed that she receives research support from GlaxoSmithKline and Celgene Corporation, and consultant fees/honoraria from GTx Inc. and Boehringer Ingelheim GmbH. The remaining authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
Presented at the International Society of Geriatric Oncology 2013 Annual Conference, October 24–26, 2013 in Copenhagen, Denmark.
This work was funded by the National Institute on Aging and the National Cancer Institute (U13 AG038151 from the National Institute on Aging and National Cancer Institute [NCI; National Institutes of Health]; R03 AG042342 U10CA37420 and R01 CA177592). The work was funded through a Patient-Centered Outcomes Research Institute (PCORI) Program Award (4634). The work was also funded by the Susan H Green Memorial Grant (to Magnuson) and by the philanthropic donation of Sandy Lloyd to the Geriatric Oncology Program at the James Wilmot Cancer Institute.
Authorship contributions: SGM was involved in the literature search, figures, study design, data collection, data analysis, data interpretation, and writing. CV was involved in the literature search, figures, study design, data collection, data interpretation, and writing. AH was involved in the study design, data interpretation, and writing (editing manuscript). AM was involved in the literature search, data analysis, data interpretation, and writing. LL was involved in the data interpretation and writing of the manuscript. CP was involved in data collection, data analysis, data interpretation, and final manuscript approval. AO was involved in the study design and data interpretation. RGB was involved in the study design, methods on the Delphi technique. WD was involved in the study design, data collection, data interpretation, and writing of the manuscript.
The authors wish to thank the following experts for their valuable time and inputs to the study: Andrew Artz, Arti Hurria, Beatriz Korc-Grodzicki, Stuart Lichtman, Aanand Naik, Lodovico Balducci, Andrew Chapman, Louise Walter, Arati Rao, Martine Extermann, Cary Gross, Martine Puts, Cynthia Owusu, Miriam Rodin, Efrat Dotan, Mary Sehl, Ajeet Gajra, Nadine Jackson McCleary, Abdo Haddad, Dale Shepard, Harvey Cohen, Sarah Kagan, Holly Holmes, Supriya Mohile, Heidi Klepin, William Tew, Hyman Muss, Tanya Wildes, Ilene Browner, Gjisberta Vanlonden, James Wallace, and William Dale.
Hurria A, Togawa K, Mohile SG. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011;29:3457–3465.
Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010;28:4086–4093.
Hurria A, Dale W, Mooney M. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol 2014;32:2587–2594.
Dale W, Mohile SG, Eldadah BA. Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst 2012;104:581–589.
Hurria A, Wildes T, Baumgartner J. NCCN Clinical Practice Guidelines in Oncology: Older Adult Oncology. Version 2.2015. Available at: NCCN.org. Accessed August 7, 2015.
Hurria A, Mohile SG, Dale W. Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Canc Netw 2012;10:286–288.
Extermann M, Boler I, Reich RR. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012;118:3377–3386.
Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011;29:3620–3627.
Wildes TM, Ruwe AP, Fournier C. Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer. J Geriatr Oncol 2013;4:227–234.
Klepin HD, Geiger AM, Tooze JA. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood 2013;121:4287–4294.
Hurria A, Balducci L, Naeim A. Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group. J Clin Oncol 2008;26:3125–3127.
Fearon K, Strasser F, Anker SD. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489–495.
Diamond IR, Grant RC, Feldman BM. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 2014;67:401–409.
Harris PA, Taylor R, Thielke R. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–381.
Decoster L, Van Puyvelde K, Mohile S. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger. Ann Oncol 2015;26:288–300.
Luciani A, Ascione G, Bertuzzi C. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and Vulnerable Elders Survey-13. J Clin Oncol 2010;28:2046–2050.
Wildiers H, Heeren P, Puts M. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32:2595–2603.
Hurria A, Gupta S, Zauderer M. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005;104:1998–2005.
Hurria A, Cirrincione CT, Muss HB. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011;29:1290–1296.
Puts MT, Hardt J, Monette J. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012;104:1133–1163.
Puts MT, Santos B, Hardt J. An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 2014;25:307–315.
Baitar A, Van Fraeyenhove F, Vandebroek A. Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer. J Geriatr Oncol 2013;4:32–38.
Hamaker ME, Mitrovic M, Stauder R. The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy. Ann Hematol 2014;93:1031–1040.
Kenis C, Bron D, Libert Y. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013;24:1306–1312.
Kenis C, Decoster L, Van Puyvelde K. Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol 2014;32:19–26.
Hamaker ME, Jonker JM, de Rooij SE. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 2012;13:e437–444.
Stuck AE, Siu AL, Wieland GD. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993;342:1032–1036.
Stuck AE, Aronow HU, Steiner A. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med 1995;333:1184–1189.
Cohen HJ, Feussner JR, Weinberger M. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002;346:905–912.
Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci 2005;60:798–803.
Caillet P, Canoui-Poitrine F, Vouriot J. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011;29:3636–3642.
Ingram SS, Seo PH, Martell RE. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 2002;20:770–775.
McCorkle R, Strumpf NE, Nuamah IF. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatr Soc 2000;48:1707–1713.
Goodwin JS, Satish S, Anderson ET. Effect of nurse case management on the treatment of older women with breast cancer. J Am Geriatr Soc 2003;51:1252–1259.
Hamaker ME, Schiphorst AH, ten Bokkel Huinink D. The effect of a geriatric evaluation on treatment decisions for older cancer patients—a systematic review. Acta Oncol 2014;53:289–296.
Chaibi P, Magne N, Breton S. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2011;79:302–307.
Seymour MT, Thompson LC, Wasan HS. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet 2011;377:1749–1759.
O'Donovan A, Mohile S, Leech M. Expert consensus panel on geriatric assessment interventions in oncology. Eur J Cancer Care (Engl) 2015;24:574–589.
Schnipper LE, Smith TJ, Raghavan D. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 2012;30:1715–1724.